|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 15.33 USD | -1.60% |
|
-7.15% | -15.58% |
| 09-20 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 08-19 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
Chart calendar Avalo Therapeutics, Inc.
Upcoming events on Avalo Therapeutics, Inc.
No events available
Past events on Avalo Therapeutics, Inc.
| 2026-06-02 | Présentation aux Actionnaires / Analystes | 08:30 |
| 2026-06-02 | Annual General Meeting | 08:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,92 1,70 13.18% | 0,44 0,22 96.44% | 0,06 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -96,9 | -133 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -27,4 -23,1 -18.4% | -68,5 -70,0 2.09% | -72,9 -71,5 -2% | -110 | -133 | -142 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,5 -26,8 -17.65% | -35,0 -14,4 -143.99% | -78,1 -80,8 3.34% | -116 | -135 | -148 |
|
Net income Million USD | Released Forecast Spread | -31,5 -26,8 -17.7% | -35,1 -108 67.6% | -78,3 -81,0 3.39% | -111 | -133 | -156 |
|
EPS USD | Released Forecast Spread | -114 -96,0 -18.75% | -7,94 -24,7 67.89% | -5,84 -6,31 7.44% | -2,84 | -2,75 | -2,63 |
| Announcement Date | 29/03/24 | 20/03/25 | 23/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,19 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,06 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -13,3 -14,7 9.25% | -14,7 -14,4 -1.75% | -19,3 -14,8 -30.38% | -19,2 -18,2 -5.75% | -19,7 -19,7 -0.37% | -20,9 -19,7 -5.85% | -31,5 -21,3 -47.84% | -28,5 | -28,9 | -31,4 | -34,4 | -37,2 | -44,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -35,2 -14,4 -144.73% | -13,1 -15,5 15.11% | -20,7 -15,4 -34.49% | -30,6 -18,8 -63.08% | -13,6 -20,8 34.69% | -19,6 -19,1 -2.78% | -36,3 -20,6 -76.2% | -29,4 | -30,2 | -30,0 | -33,6 | -37,2 | -45,3 |
|
Net income Million USD | Released Forecast Spread | -35,3 -14,2 -149.31% | -13,1 -14,9 11.56% | -20,8 -15,2 -36.75% | -30,6 -18,8 -63.31% | -13,7 -20,6 33.32% | -19,6 -19,2 -2.46% | -36,4 -21,0 -73.51% | -28,3 | -28,6 | -29,9 | -33,0 | -36,0 | -42,7 |
|
EPS USD | Released Forecast Spread | -7,95 -1,52 -424.41% | -1,25 -1,06 -18.48% | -1,92 -1,40 -37% | -2,19 -1,66 -32.03% | -0,37 -1,47 74.83% | -0,98 -1,03 4.44% | -0,83 -0,60 -38.52% | -0,62 | -0,55 | -0,66 | -0,73 | -0,80 | -0,92 |
| Announcement Date | 20/03/25 | 12/05/25 | 07/08/25 | 06/11/25 | 23/03/26 | 13/05/26 | 06/08/26 | - | - | - | - | - | - |
| 2026-10-01 |  | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-10-06 | | Information meeting | 10:00 |
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 |
Past sector events for Avalo Therapeutics, Inc.
| Today | | Information meeting | 13:00 |
| 2026-09-29 | | Extraordinary General Meeting | 02:00 |
| 2026-09-29 | | Information meeting | 08:00 |
| 2026-09-29 | | Information meeting | 08:30 |
| 2026-09-29 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-09-28 | | Information meeting | 08:30 |
| 2026-09-28 | | Earnings release - Q2 2026 | |
| 2026-09-28 | | Earnings presentation | 08:00 |
| 2026-09-25 | | Earnings presentation | 09:00 |
| 2026-09-24 | | Annual General Meeting | 09:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AVTX Stock
- Calendar Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
